Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial

OBJECTIVE: To evaluate the cost-effectiveness of percutaneous coronary intervention (PCI) compared with placebo in patients with single-vessel coronary artery disease and angina despite anti-anginal therapy. DESIGN: A cost-effectiveness analysis comparing PCI with placebo. A Markov model was used to...

Descripción completa

Detalles Bibliográficos
Autores principales: McCreanor, Victoria, Nowbar, Alexandra, Rajkumar, Christopher, Barnett, Adrian G, Francis, Darrel, Graves, Nicholas, Boden, William E, Weintraub, William S, Al-Lamee, Rasha, Parsonage, William A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875263/
https://www.ncbi.nlm.nih.gov/pubmed/33563623
http://dx.doi.org/10.1136/bmjopen-2020-044054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875263/
https://www.ncbi.nlm.nih.gov/pubmed/33563623
http://dx.doi.org/10.1136/bmjopen-2020-044054

Ejemplares similares